Mirae Asset Global Etfs Holdings Ltd. Adma Biologics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 140,066 shares of ADMA stock, worth $2.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
140,066
Previous 147,165
4.82%
Holding current value
$2.04 Million
Previous $2.92 Million
12.64%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
403Shares Held
197MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$312 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$272 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$187 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86.3 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...